FDA Submits Information Collection for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, to ensure consistency with FDA-recommended labeling and recommendations for pharmaceutical and medical device communications with payors, formulary committees, and similar entities.